Loading data for ACIXF — first visit, this takes a few seconds.
Acarix AB (publ)（ACIXF）の株価・分析・データ
本質的価値
アナリスト予想
株価予想 →最新決算
| 実績 | 予想との差 | 前年比 | |
|---|---|---|---|
| 売上高 | — | n/a | n/a |
| EPS（TTM） | — | n/a | n/a |
事業指標
Acarix AB (publ)について
企業情報を見る →Acarix AB (publ), a medical device company, develops solutions for rapid AI-based coronary artery disease rule-out. The company offers CADScor System, a point-of-care diagnostic aid that uses sensitive acoustics and advanced computational processing to support clinical decision making at the point of care. It sells its products in the Nordic countries, the United Kingdom, Germany, Switzerland, Austria, Mauritius, and the United States. The company was founded in 2009 and is headquartered in Malmö, Sweden.
Acarix AB (publ), a medical device company, develops solutions for rapid AI-based coronary artery disease rule-out. The company offers CADScor System, a point-of-care diagnostic aid that uses sensitive acoustics and advanced computational processing to support clinical decision making at the point of care. It sells its products in the Nordic countries, the United Kingdom, Germany, Switzerland, Austria, Mauritius, and the United States. The company was founded in 2009 and is headquartered in Malmö, Sweden.
セクター Healthcare
IPO日 Dec 7, 2022
従業員数 8
上場取引所 OTC Markets OTCQB
ティッカー ACIXF
ウェブサイト https://www.acarix.com